Caitlin Colling is an Endocrinology/Metabolic physician affiliated with Harvard University. OpenAlex indexes 45 publications with 379 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Massachusetts General Hospital
50 Staniford Street
Boston, MA 02114
Telephone
617-726-8722Provider last certified this registry record 14 Mar 2022.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novo Nordisk IncProgram year20242 payments
- Novo Nordisk IncProgram year20235 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
87%GLP-1 receptor agonist46.5%Ozempic55%Trulicity23%Mounjaro19%Rybelsus4%Part D<11 patientsSGLT2 inhibitor11.4%Jardiance77%Farxiga23%Part D<11 patients+ 6 more classes in this area
Cardiovascular
4.2%Statin2.2%Atorvastatin Calcium100%Part D<11 patientsACE inhibitor2%Lisinopril100%Part D<11 patientsHormonal (systemic)
4.2%l-Thyroxine4.2%Levothyroxine Sodium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Expanding Access to Continuous Glucose Monitoring Through Empowering Primary Care: A Joint Endocrinology-Primary Care Quality Improvement Project
Journal of General Internal Medicine
2025 - Case 8-2025: A 72-Year-Old Woman with Altered Mental Status and Acidemia
New England Journal of Medicine
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Joseph Antin, MD
Harvard University
Sarah Fortune, MD
Harvard University
Elizabeth Buchbinder, MD
Harvard University
Ethan Lerner, MD
Harvard University
Yousef Saleh Khader
Jordan University of Science and Technology
Jens Juul Holst
University of Copenhagen
Victor Montori, MD
Mayo Clinic
Christos Mantzoros, MD
Harvard Medical School
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”